287 filings
Page 6 of 15
4
bilwxzquloo64a8zlms
24 Jun 22
Athira Pharma / KEVIN CHURCH ownership change
7:25pm
8-K
k51bt6wxrgma0qx
22 Jun 22
Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
7:05am
4
sq5cih fusfq5muxmf7
10 Jun 22
Athira Pharma / KEVIN CHURCH ownership change
5:53pm
4
z2uy8
27 May 22
Athira Pharma / GRANT PICKERING ownership change
5:51pm
4
qvk5mazgz3nbxi4n
27 May 22
Athira Pharma / Kelly A Romano ownership change
5:49pm
4
9cwero4u0l9k 3t
27 May 22
Athira Pharma / Barbara Kosacz ownership change
5:47pm
4
p4yj 6zt8t0dc
27 May 22
Athira Pharma / JOSEPH EDELMAN ownership change
5:45pm
4
70su5z4
27 May 22
Athira Pharma / JOHN M FLUKE JR ownership change
5:42pm
4
gl0lmpzl0xld4eg2x cb
27 May 22
Athira Pharma / JAMES A JOHNSON ownership change
5:40pm
4
xxfv13gky2
27 May 22
Athira Pharma / Michael A. Panzara ownership change
5:38pm
4
fa29cv1f171fzgyymj
27 May 22
Change in insider ownership
5:19pm
8-K
mx5lw3ryk 1qa
24 May 22
Submission of Matters to a Vote of Security Holders
5:01pm
DEFA14A
n5qxs4
17 May 22
Additional proxy soliciting materials
6:06am
DEFA14A
rodag 99kev
16 May 22
Additional proxy soliciting materials
6:32pm
DFAN14A
hv9alq 7clm
16 May 22
Additional proxy materials by non-management
2:04pm
8-K
89z86rd
12 May 22
Athira Pharma Reports First Quarter 2022 Financial Results
4:12pm
DFAN14A
hso7 o3ugg0x
12 May 22
Additional proxy materials by non-management
2:06pm
DEFA14A
motdi37dgaqsa04m
11 May 22
Additional proxy soliciting materials
4:49pm
DEFA14A
l0z2vxut 3rf
9 May 22
Additional proxy soliciting materials
4:32pm